Skip to main content
logo
GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.99
+0.09 (0.18%)
At close: May 13, 2026, 4:00 PM EDT
50.99
0.00 (0.00%)
After-hours: May 13, 2026, 7:00 PM EDT

Revenue Breakdown

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
HIV Revenue
7.80B7.69B7.09B
HIV Revenue Growth
1.43%8.44%10.01%
Respiratory, Immunology and Inflammation Revenue
3.90B3.81B3.30B
Respiratory, Immunology and Inflammation Revenue Growth
2.26%15.49%9.06%
Oncology Revenue
2.07B1.98B1.41B
Oncology Revenue Growth
4.91%40.21%92.89%
Specialty Medicines Revenue
13.77B13.47B11.81B
Specialty Medicines Revenue Growth
2.17%14.09%15.29%
Shingles Revenue
3.72B3.56B3.36B
Shingles Revenue Growth
4.47%5.77%-2.38%
Meningitis Revenue
1.57B1.58B1.44B
Meningitis Revenue Growth
-0.95%10.16%14.05%
Influenza Revenue
312.00M303.00M408.00M
Influenza Revenue Growth
2.97%-25.74%-19.05%
Other Paediatric & Adult Vaccines Revenue
3.03B3.12B3.34B
Other Paediatric & Adult Vaccines Revenue Growth
-2.76%-6.56%2.23%
Vaccines Revenue
9.21B9.16B9.14B
Vaccines Revenue Growth
0.59%0.21%-7.36%
Respiratory Revenue
6.95B7.07B7.21B
Respiratory Revenue Growth
-1.64%-2.01%5.68%
Other General Medicines Revenue
2.85B2.97B3.22B
Other General Medicines Revenue Growth
-3.98%-7.68%-5.30%
General Medicines Revenue
9.80B10.04B10.43B
General Medicines Revenue Growth
-2.33%-3.76%2.04%
Revenue (Total)
32.78B32.67B31.38B
Revenue (Total) Growth
0.35%4.12%3.46%

Revenue Breakdown 2

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Total Commercial Operations Revenue
32.78B32.67B31.38B
Total Commercial Operations Revenue Growth
0.35%4.12%3.46%
Revenue (Total)
32.78B32.67B31.38B
Revenue (Total) Growth
0.35%4.12%3.46%

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
US Revenue
16.84B16.86B16.38B
US Revenue Growth
-0.09%2.90%3.56%
Europe Revenue
7.87B7.53B6.67B
Europe Revenue Growth
4.43%13.01%1.55%
International Revenue
8.07B8.28B8.33B
International Revenue Growth
-2.49%-0.61%4.81%
Revenue (Total)
32.78B32.67B31.38B
Revenue (Total) Growth
0.35%4.12%3.46%

EBIT

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Commercial Operations Segment Profit
16.49B16.26B15.34B
Commercial Operations Segment Profit Growth
1.43%6.03%4.63%
Research & Development Segment Profit
-6.33B-6.25B-5.85B
Operating Income (Other)
-2.16B-2.08B-5.47B
Operating Income (Total)
8.01B7.93B4.02B
Operating Income (Total) Growth
0.97%97.26%-40.38%
Updated Apr 29, 2026. Data Source: Fiscal.ai.